Colorectal Neoplasms: all 5,734 studies

Page 50 of 58. Open to participants first (1,481), then studies with results posted, then the rest; newest registration first within each.

• Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer PatientsStatus unknownNCT01157052Phase 1
• A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of OxaliplatinWithdrawnNCT01157039Phase 2
• KRAS Mutation and Incidence of the Colorectal Carcinoma in Martinique Between 2007 and 2009CompletedNCT01151007
• High Dose Vitamin D StudyCompletedNCT01150877Phase 1/2
• A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line ChemotherapyStatus unknownNCT01144195Phase 2
• Impact of Early and Active Nutritional and Dietary Management grade3 or More Toxicities Induced by Chemotherapy and Targeted Therapies Administered to Patients as First Intention for Non Surgical Metastatic Colorectal CancerCompletedNCT01143285Not applicable
• Study of Patient Navigation to Promote Colon Cancer ScreeningCompletedNCT01141114Not applicable
• Increasing Colorectal Cancer Screening in Urban African American Communities Via ChurchesCompletedNCT01139242Not applicable
• Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal CancerCompletedNCT01139138Phase 1/2
• Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR InhibitorsTerminatedNCT01137162
• An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal CancerTerminatedNCT01134666
• A Post-Marketing Surveillance Study On Erbitux® (Cetuximab) In Patients With Metastatic Colorectal Cancer Refractory To Irinotecan Containing TreatmentCompletedNCT01134640
• Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified ChemotherapyTerminatedNCT01126866Phase 2
• Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal CancerCompletedNCT01126112Phase 2
• Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other TreatmentsCompletedNCT01124630Phase 1
• Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With ColorecCompletedNCT01116271Phase 2
• Efficacy of Cap-assisted Chromoendoscopy as a Screening Test for Colorectal Neoplasm Using Web-based Research NetworkCompletedNCT01112280Not applicable
• Endoscopic Submucosal Dissection Versus Laparoscopic Resection for Early Colorectal NeoplasmsStatus unknownNCT01112046Phase 3
• Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in ChinaCompletedNCT01110941Phase 1/2
• J-Pouch Colorectal Anastomosis or Straight Colorectal Anastomosis in Treating Patients With Rectal Cancer Who Have Undergone Surgery to Remove the TumorStatus unknownNCT01110798Not applicable
• Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal CancerStatus unknownNCT01110785Phase 2
• Pemetrexed and Gemcitabine for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS MutationsTerminatedNCT01109615Phase 2
• A Randomised Trial of Pulmonary Metastasectomy in Colorectal CancerCompletedNCT01106261Not applicable
• Increasing Colorectal Cancer (CRC) Screening In Primary CareCompletedNCT01099826Not applicable
• Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal CancerCompletedNCT01097018Phase 3
• Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal MetastasesWithdrawnNCT01095523Phase 2
• Oral Glutamine in the Prevention of Oxaliplatin-induced NeurotoxicityCompletedNCT01087658Phase 3
• Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation CourseCompletedNCT01086683Phase 2/3
• Chemotherapy With or Without Surgery in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryCompletedNCT01086618Phase 2/3
• Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal CancerCompletedNCT01086267Phase 1/2
• Tailored Interactive Intervention to Increase CRCSCompletedNCT01084746Not applicable
• Prevalence of the Mutational Status of V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) in Metastatic Colorectal Cancer (mCRC) in Argentine PatientsCompletedNCT01082757
• A Korean Post-marketing Surveillance Study on Erbitux® in Patients With Metastatic Colorectal Cancer Refractory to Irinotecan-containing TreatmentCompletedNCT01082315
• Initiation of Colon Cancer Screening in Veterans or "Start Screening Now"CompletedNCT01079533Not applicable
• Changes in Stem Cells of the Colon in Response to Increased Risk of Colorectal CancerCompletedNCT01075893
• Colorectal Cancer Screening in Familiar-Risk Population: Immunochemical Fecal Occult Blood Testing Versus ColonoscopyCompletedNCT01075633Phase 3
• Dignity Therapy in mCRC to Increase Peaceful Awareness & Impact Goals of Care Decision-MakingCompletedNCT01074385Not applicable
• An Observational Study of Erbitux® in Patients With Metastatic Colorectal Cancer (mCRC) Refractory to Irinotecan-containing TreatmentTerminatedNCT01074333
• Resection of Colorectal Liver Metastases With or Without Routine Hilar LymphadenectomyStatus unknownNCT01073358Not applicable
• Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus PrintCompletedNCT01072851Phase 3
• Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal CancerCompletedNCT01071655Phase 2
• Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver MetastasesCompletedNCT01070355Phase 2
• Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab.CompletedNCT01068132Phase 2
• Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.Status unknownNCT01067053Phase 2
• Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV CancerCompletedNCT01065441Phase 1/2
• Safety Study of DNA Vaccine Delivered by Intradermal Electroporation to Treat Colorectal CancerCompletedNCT01064375Phase 1/2
• TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal CancerTerminatedNCT01060423Phase 2
• Treatment Strategies for Primarily Generalized Colorectal CancerTerminatedNCT01056809Not applicable
• Compression Anastomosis For Low Anterior Resection in Previously Radiated Patients Using the CAR™ 27Status unknownNCT01056796Phase 2
• Performance Study of the Invendo C20 Colonoscope System in Colorectal Cancer ScreeningCompletedNCT01054924
• Dose Adaptation of Capecitabine Using Mobile Phone Toxicity MonitoringCompletedNCT01053104
• Bi-weekly Cetuximab Combined With 5-fluorouracil/Leucovorin/Oxaliplatin (FOLFOX-6) in Metastatic Colorectal CancerCompletedNCT01051167Phase 2
• Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI TumorStatus unknownNCT01048463Phase 3
• QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal CancerCompletedNCT01040000Phase 1/2
• An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC)CompletedNCT01039506
• Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 WeeksStatus unknownNCT01037049Phase 2
• Compare FOFLOX4 in Preoperative and Postoperative and Postoperative in Resectable Liver Metastasis Colorectal Cancer (MCC)Status unknownNCT01035385Phase 3
• Personal Electronic Health Records in Improving Screening Rates for Colorectal CancerStatus unknownNCT01032746Not applicable
• Internet-Based Weight-Loss Program for Colorectal Cancer SurvivorsWithdrawnNCT01032590Not applicable
• Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal CancersWithdrawnNCT01031056
• Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic PatientsCompletedNCT01030042Phase 3
• Innovative Tools to Improve Colorectal Cancer Screening Rates in ManitobaCompletedNCT01026753Not applicable
• Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal CancerCompletedNCT01024504Phase 2
• OPTIMOX1 in Chinese mCRC PatientsStatus unknownNCT01023633Phase 4
• Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal CancerCompletedNCT01022541Phase 2
• OSI-906 and Irinotecan in Patients With Advanced CancerTerminatedNCT01016860Phase 1
• Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal CancerCompletedNCT01016639Phase 1/2
• Telemark Polyp Study, a Trial on Colonoscopy ScreeningCompletedNCT01014039Not applicable
• Colorectal Cancer Survivors' Needs and Preferences for Survivorship InformationCompletedNCT01003600
• Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)Status unknownNCT00997685Phase 2
• Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal CancerCompletedNCT00995202Phase 3
• Processed Meat and Colon CarcinogenesisCompletedNCT00994526Not applicable
• A New Method for Colorectal Cancer Screening: Colon Capsule Endoscopy Compared to Conventional EndoscopyCompletedNCT00991003Not applicable
• Sorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS MutationCompletedNCT00989469Phase 1/2
• Colorectal Cancer RECHALLENGEWithdrawnNCT00988897Phase 2
• T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety StudyCompletedNCT00986518Phase 1/2
• Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal CancerCompletedNCT00984048
• Colorectal Cancer Screening for Cancer SurvivorsCompletedNCT00982059
• Standard Versus Advanced Antimicrobial Dressing Containing Ionic Silver Following Colorectal Cancer SurgeryCompletedNCT00981110Phase 3
• Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GISTCompletedNCT00979329
• Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal CancerCompletedNCT00975897Phase 2/3
• Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.CompletedNCT00974610
• S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by SurgeryStatus unknownNCT00974389Phase 2
• Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal SurgeryStatus unknownNCT00973869Phase 1
• Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)CompletedNCT00973609Phase 3
• Study of Nimotuzumab to Treat Colorectal CancerStatus unknownNCT00972465Phase 2
• Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump ChemotherapyCompletedNCT00972036Phase 1
• CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With OxaliplatinTerminatedNCT00969033Phase 2
• 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid TumorsCompletedNCT00967577Phase 1
• Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal CancerCompletedNCT00966667
• Comprehensibility of Colorectal Cancer Screening Educational Materials: Effects on Patient Knowledge and MotivationCompletedNCT00965965Not applicable
• Cancer: Thriving and Surviving Online Workshop and Study for Cancer SurvivorsCompletedNCT00962494Phase 2
• The Continuing Care Needs in Colorectal Cancer Patients in Different StagesStatus unknownNCT00961129
• Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By SurgeryWithdrawnNCT00960427Phase 1
• Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA)CompletedNCT00958386Phase 2
• Increasing Primary Care Physician Colorectal Cancer Screening RatesCompletedNCT00955344Not applicable
• Computer-Based Tailored or Standard Information for Colorectal Cancer ScreeningCompletedNCT00955188
• Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal CancerWithdrawnNCT00954876Phase 2
• Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00952029Phase 2/3
• Methotrexate in Metastatic Colorectal Cancer With MSH2 DeficiencyTerminatedNCT00952016Phase 2

← Colorectal Neoplasms overview